🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 14/09/2022 | 0,6900 USD |
| 14/06/2022 | 0,6900 USD |
| 14/03/2022 | 0,6900 USD |
| 14/12/2021 | 0,6900 USD |
| 14/09/2021 | 0,6500 USD |
| 14/06/2021 | 0,6500 USD |
| 12/03/2021 | 0,6202 USD |
| 14/12/2020 | 0,6202 USD |
| 14/09/2020 | 0,5821 USD |
| 12/06/2020 | 0,5821 USD |
| 13/03/2020 | 0,5821 USD |
| 13/12/2019 | 0,5821 USD |
| 13/09/2019 | 0,5248 USD |
| 14/06/2019 | 0,5248 USD |
| 14/03/2019 | 0,5248 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 22/06/2012 | 37,79 | 38,46 | 37,74 | 38,34 | +1,85% | 1,92% | 25.306.999 |
| 21/06/2012 | 37,56 | 37,97 | 37,49 | 37,64 | +0,61% | 1,27% | 18.166.766 |
| 20/06/2012 | 37,38 | 37,58 | 37,21 | 37,41 | -0,05% | 0,97% | 11.939.026 |
| 19/06/2012 | 37,17 | 37,61 | 37,08 | 37,43 | +0,98% | 1,44% | 12.472.353 |
| 18/06/2012 | 36,95 | 37,27 | 36,95 | 37,07 | -0,23% | 0,88% | 8.651.135 |
| 15/06/2012 | 37,23 | 37,31 | 37,09 | 37,16 | +0,39% | 0,59% | 16.823.544 |
| 14/06/2012 | 36,76 | 37,16 | 36,59 | 37,01 | +1,02% | 1,53% | 13.529.261 |
| 13/06/2012 | 36,64 | 37,01 | 36,52 | 36,64 | -1,16% | 1,35% | 12.121.692 |
| 12/06/2012 | 36,84 | 37,07 | 36,63 | 37,07 | +0,99% | 1,19% | 10.969.416 |
| 11/06/2012 | 36,85 | 36,99 | 36,68 | 36,71 | +0,03% | 0,85% | 49.061.386 |
| 08/06/2012 | 36,72 | 36,78 | 36,50 | 36,70 | +0,34% | 0,78% | 53.368.666 |
| 07/06/2012 | 36,33 | 36,71 | 36,27 | 36,57 | +1,13% | 1,21% | 55.932.703 |
| 06/06/2012 | 36,02 | 36,16 | 35,81 | 36,16 | +1,07% | 0,98% | 13.219.367 |
| 05/06/2012 | 35,69 | 35,83 | 35,55 | 35,78 | +0,11% | 0,78% | 11.067.404 |
| 04/06/2012 | 35,48 | 35,75 | 35,42 | 35,74 | +0,75% | 0,94% | 11.439.758 |
| 01/06/2012 | 35,48 | 35,77 | 35,32 | 35,48 | -1,06% | 1,26% | 14.013.437 |
| 31/05/2012 | 35,89 | 36,14 | 35,54 | 35,86 | +0,48% | 1,65% | 14.088.369 |
| 30/05/2012 | 35,69 | 35,93 | 35,58 | 35,69 | -0,51% | 0,96% | 10.132.274 |
| 29/05/2012 | 35,96 | 36,02 | 35,72 | 35,87 | +0,11% | 0,85% | 9.214.435 |
| 25/05/2012 | 35,85 | 36,02 | 35,66 | 35,83 | -0,13% | 1,01% | 6.907.997 |
| 24/05/2012 | 35,69 | 35,94 | 35,57 | 35,88 | +0,70% | 1,04% | 9.066.982 |
| 23/05/2012 | 35,74 | 35,91 | 35,32 | 35,63 | -0,32% | 1,63% | 11.776.166 |
| 22/05/2012 | 35,94 | 36,01 | 35,64 | 35,74 | -0,37% | 1,04% | 12.919.325 |
| 21/05/2012 | 36,00 | 36,15 | 35,83 | 35,88 | -0,58% | 0,90% | 9.746.400 |
| 18/05/2012 | 36,45 | 36,46 | 35,91 | 36,09 | -0,55% | 1,52% | 19.587.749 |
| 17/05/2012 | 36,46 | 36,69 | 36,26 | 36,29 | -0,52% | 1,18% | 14.573.488 |
| 16/05/2012 | 36,22 | 36,59 | 36,04 | 36,48 | +1,30% | 1,53% | 16.105.245 |
| 15/05/2012 | 36,34 | 36,45 | 35,86 | 36,01 | -1,26% | 1,63% | 11.164.030 |
| 14/05/2012 | 36,12 | 36,63 | 35,98 | 36,47 | +0,50% | 1,80% | 17.053.790 |
| 11/05/2012 | 36,45 | 36,58 | 36,21 | 36,29 | -0,94% | 1,02% | 12.692.747 |